Sandoz Does Not Budge On 2022 Expectations Despite Positive Start
Q1 Revenues Improve By 8% At CCs While Bottom Line Soars – With Caveats
A weak base for the prior year and several one-time items allowed Sandoz to post positive financial results for the first quarter of 2022, including a 26% jump in the company’s core operating profit. Electing not to upgrade its expectations for Sandoz this year, Novartis will continue to monitor the business amid an ongoing strategic review.
